EP0702712B1 - Synergistically stabilized liquid enzymatic compositions - Google Patents
Synergistically stabilized liquid enzymatic compositions Download PDFInfo
- Publication number
- EP0702712B1 EP0702712B1 EP94919433A EP94919433A EP0702712B1 EP 0702712 B1 EP0702712 B1 EP 0702712B1 EP 94919433 A EP94919433 A EP 94919433A EP 94919433 A EP94919433 A EP 94919433A EP 0702712 B1 EP0702712 B1 EP 0702712B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- enzyme
- liquid enzymatic
- poly
- formulation
- ether
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Revoked
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38663—Stabilised liquid enzyme compositions
Definitions
- the present invention relates to novel formulations for stabilizing at least one enzyme contained in a liquid enzymatic composition.
- the unique rheological properties of the components of these stabilizing formulations preferably afford synergistic stabilizing capacity over other water-based mixtures of enzymatic dispersions, even under conditions of moderate to high heat and wide pH ranges.
- the invention therefore, also relates to stabilized liquid enzymatic compositions. Additionally, the invention relates to novel methods for the preparation of stabilized liquid enzymatic compositions, and methods using the stabilizing formulations with liquid enzymatic compositions.
- enzymes and liquid enzymatic compositions in industry and in the commercial marketplace has grown rapidly over the last several years.
- enzymes can be acid, alkaline or neutral, depending upon the pH range in which they are active. All of these types of enzymes are contemplated to be useful in connection with the invention disclosed herein.
- enzymes and liquid enzymatic compositions have been associated with liquid detergents and have shown utility as solubilizing and cleaning formulations. In addition to their association with liquid detergents, enzymes and liquid enzymatic compositions have also shown utility in a number of different commercial and industrial areas in which a wide variety of enzyme classes are now used.
- Proteases are a well-known class of enzymes frequently utilized in a wide variety of industrial applications where they act to hydrolyze peptide bonds in proteins and proteinaceous substrates.
- Commercially, the greatest uses of proteases are made in the laundry detergent industry, where they help to remove protein-based stains such as blood or egg stains, and in the cheese-making industry, where they aid in curdling milk.
- Proteases are also used as meat tenderizers, for softening leather, for modifying food ingredients, and for flavor development.
- Liquid enzymatic compositions containing alkaline proteases have also shown to be useful as dispersants of bacterial films and algal and fungal mats in cooling tower waters and metalworking fluid containment bays.
- Proteases can be characterized as acid, neutral, or alkaline proteases depending upon the pH range in which they are active.
- the acid proteases include the microbial rennets, rennin (chymosin), pepsin, and fungal acid proteases.
- the neutral proteases include trypsin, papain, bromelain/ ficin, and bacterial neutral protease.
- the alkaline proteases include subtilisin and related proteases.
- Amylases another class of enzymes, have also been utilized in many industrial and commercial processes in which they act to catalyze or accelerate the hydrolysis of starch.
- Amylases are used largely in the corn syrup industry for the production of glucose syrups, maltose syrups, and a variety of other more refined end products of starch hydrolysis such as high fructose syrups.
- they include ⁇ -amylase, ⁇ -amylase, amyloglucosidase (glucoamylase), fungal amylase, and pullulanase.
- liquid enzymatic compositions containing amylases are available under the names BAN, Termamyl®, AMG, Fungamyl®, and PromozymeTM, which are supplied by Novo Nordisk, and Diazyme L-200, a product of Solvay Enzyme Products.
- cellulases are enzymes that degrade cellulose, a linear glucose polymer occurring in the cell walls of plants.
- Hemicellulases are involved in the hydrolysis of hemicellulose which, like cellulose, is a polysaccharide found in plants.
- the pectinases are enzymes involved in the degradation of pectin, a carbohydrate whose main component is a sugar acid.
- ⁇ -glucanases are enzymes involved in the hydrolysis of ⁇ -glucans which are also similar to cellulose in that they are linear polymers of glucose. In a commercial context, these enzymes have utility to a greater or lesser degree in manufacturing processes dependent on fiber degradation.
- Cellulases have reported utility in the de-inking process of old newsprint (ONP) wastepaper, eliminating the need for any surfactants and alkaline chemicals.
- the enzymes dislodge inks from fiber surfaces and disperse ink particles to a finite size. See S. Say-Kyoun Ow, Biological De-Inking Methods of Newsprint Wastepaper, World Pulp and Paper Technology, pp. 63, 64 (1992).
- cellulases include endocellulase, exocellulase, exocello-biohydrolase, mannase, and cellobiase.
- Commercial liquid enzymatic compositions containing cellulases are available under the names Celluclast® and Novozym®188 which are both supplied by Novo Nordisk.
- Hemicellulases are also used in the de-inking process to dislodge ink particles from the fiber surface of ONP. See D. Y. Prasad et al., Enzyme Deinking of Black and White Letterpress Printed Newsprint Waste, Progress in Paper Recycling, May 1992, pp. 21, 22. Additionally, hemicellulases, such as the xylanases, are employed in the pulp bleaching process. Xylanase pretreatment of kraft pulps has resulted in major reductions in bleaching chemical requirements, such as molecular chlorine, and has also improved pulp quality as reflected by higher brightness ceilings. See D. J.
- hemicellulases include hemicellulase mixture and galactomannanase.
- Commercial liquid enzymatic compositions containing hemicellulases are available as PULPZYM® from Novo, ECOPULP® from Alko Biotechnology and Novozym®280 and GamanaseTM, which are both products of Novo Nordisk.
- pectinases are used commercially to weaken cell walls and enhance extraction of fruit juice, as well as to aid in decreasing viscosity and preventing gelation in these extracts.
- Pectinases consist of endopolygalacturonase, exopoly-galacturonase, endopectate lyase (transeliminase), exopectate lyase (transeliminase), and endopectin lyase (transeliminase).
- Commercial liquid enzymatic compositions containing pectinases are available under the names PectinexTM Ultra SP and PectinexTM*, both supplied by Novo Nordisk.
- ⁇ -glucanases play an important role in the malting and brewing industries where modification of barley cell walls containing ⁇ -glucans is necessary.
- ⁇ -glucanases are comprised of lichenase, laminarinase, and exoglucanase.
- Commercial liquid enzymatic compositions containing ⁇ -glucanases are available under the names Novozym®234, Cereflo®, BAN, Finizym®, and Ceremix®, all of which are supplied by Novo Nordisk.
- Lipases and phospholipases are esterase enzymes which hydrolyze fats and oils by attacking the ester bonds in these compounds. Lipases act on triglycerides, while phospholipases act on phospholipids. In the industrial sector, lipases and phospholipases represent the commercially available esterases, and both currently have a number of industrial and commercial applications.
- liquid enzyme preparations containing lipases have proven to be particularly useful in reducing pitch deposits on rolls and other equipment during the production process.
- the treatment of unbleached sulfite pulp with lipases prior to bleaching with chlorine to reduce the content of chlorinated triglycerides, which are reportedly the cause of pitch deposition during the paper manufacturing process has been reported.
- Novo Nordisk markets two liquid lipase preparations under the names ResinaseTM A and ResinaseTM A 2X, both of which, under certain conditions, reportedly reduce pitch deposits significantly by breaking down wood resins in pulp.
- lipases Another important use of lipases is to degrease hides and pelts in the leather-making process.
- Alkaline lipases are used in conjunction with special proteases and emulsifying systems to aid degreasing, as well as to improve the soaking and liming effect in leather-making. See J. Christner, The Use of Lipases in the Beamhouse Processes, 87 J.A.L.C.A. 128 (1992).
- Lipases have also been used for the development of flavors in cheese and to improve the palatability of beef tallow to dogs. In nonaqueous systems, lipases have been employed to synthesize esters from carboxylic acids and alcohols.
- liquid enzymatic compositions containing lipases are available.
- lipases are available under the trade names Lipolase 100, Greasex 50L, PalataseTMA, PalataseTMM, and LipozymeTM which are all supplied by Novo Nordisk.
- pancreatic phospholipase A 2 has been used to convert lecithin into lysolecithin.
- Lysolecithin reportedly is an excellent emulsifier in the production of mayonnaise and the baking of bread.
- phospholipase A 2 is available in a liquid enzymatic composition sold as LECITASETM by Novo Nordisk.
- the isomerases are particularly important in the high fructose corn syrup industry.
- the aldose-ketose isomerase reaction catalyzed by glucose isomerase, involves the conversion of glucose to fructose and is just one of three key enzyme reactions in the industry.
- Sweetzyme® product is a liquid enzymatic composition containing glucose isomerase which is supplied by Novo Nordisk.
- Redox enzymes are enzymes that act as catalysts in chemical oxidation/reduction reactions and, consequently, are involved in the breakdown and synthesis of many biochemicals.
- redox enzymes have not gained a prominent place in industry since most redox enzymes require the presence of a cofactor.
- cofactors are an integral part of an enzyme or do not have to be supplied, redox enzymes are commercially useful, particularly in the food processing industry.
- the redox enzyme glucose oxidase
- Glucose oxidase is also used as an "oxygen scavenger" to prevent the development of off-flavors in juices and to preserve color and stability in certain sensitive food ingredients.
- the redox enzyme, catalase has been utilized to decompose residual hydrogen peroxide used as a sterilizing agent.
- redox enzymes have possible applications ranging from the enzymatic synthesis of steroid derivatives to use in diagnostic tests. These redox enzymes include peroxidase, superoxide dismutase, alcohol oxidase, polyphenol oxidase, xanthine oxidase, sulfhydryl oxidase, hydroxylases, cholesterol oxidase, laccase, alcohol dehydrogenase, and steroid dehydrogenases.
- enzymes When enzymes, such as those described above, are prepared or sold for use in industrial processes, they generally are formulated as water-based or aqueous liquid enzymatic compositions designed for a particular process. Water-based liquid enzymatic compositions may contain additional solvents depending upon the particular enzyme or use of the composition. These liquid enzymatic compositions, however, have historically been plagued with problems such as chemical instability which can result in the loss of enzymatic activity, particularly upon storage. This critical problem of loss of enzymatic activity upon storage has particularly affected the liquid detergent industry.
- the stabilization of an aqueous enzyme preparation using certain esters has been described in U.S. Patent No. 4,548,727.
- the ester used as a stabilizer has the formula, RCOOR', where R is an alkyl of from one to three carbons or hydrogen, and R' is an alkyl of from one to six carbons.
- the ester is present in the aqueous enzyme preparation in an amount from 0.1 to about 2.5% by weight.
- U.S. Patent No. 4,318,818 describes a stabilizing system for aqueous enzyme compositions where the stabilizing system comprises calcium ions and a low molecular weight carboxylic acid or its salt.
- the pH of the stabilizing system is from about 6.5 to about 10.
- U.S. Patent No. 4,243,543 teaches the stabilization of liquid proteolytic enzyme-containing detergent compositions.
- the detergent compositions are stabilized by adding an antioxidant and a hydrophilic polyol to the composition while stabilizing the pH of the composition.
- U.S. Patent No. 4,169,817 teaches a liquid cleaning composition containing stabilized enzymes.
- the composition is an aqueous solution containing from 10% to 50% by weight of solids and including detergent builders, surface active agents, an enzyme system derived from Bacillus subtilis and an enzyme stabilizing agent.
- the stabilizing agents comprise highly water soluble sodium or potassium salts and/or water soluble hydroxy alcohols and enable the solution to be stored for extended periods without deactivation of the enzymes.
- European Patent No. 0 352 244 A2 describes stabilized liquid detergent compositions using an amphoteric surfactant.
- the present invention provides a formulation capable of synergistically stabilizing one or more enzymes contained in a liquid enzymatic composition.
- the invention thus, also provides stabilized liquid enzymatic compositions.
- the invention provides methods for the preparation of stabilized liquid enzymatic compositions.
- a formulation for stabilizing a liquid enzymatic composition comprising:
- the inventive stabilizing formulation can be used with a wide variety of enzymes utilized in liquid enzymatic compositions performing a wide variety of functions.
- the enzymes and classes of enzymes with which this stabilizing formulation can be used include, but are not limited to, those discussed above.
- the invention also relates to a stabilized liquid enzymatic composition
- a stabilized liquid enzymatic composition comprising:
- the invention further relates to a method for the preparation of a stabilized liquid enzymatic composition by combining an enzyme with the stabilizing formulation above. Additionally, the invention relates to a method of using the stabilizing formulation to stabilize a liquid enzymatic formulation comprising the step of combining the stabilizing formulation with a liquid enzymatic composition.
- the invention provides a formulation for stabilizing a liquid enzymatic composition comprising:
- a water-soluble, or at least partially water-soluble, polymer is used in a formulation for stabilizing a liquid enzymatic composition or a stabilized liquid enzymatic compositions of the invention. That is, the polymer must have sufficient solubility to be miscible with water and form a single phase. Having this solubility, the polymer should not separate out when combined with the C 2 -C 6 polyhydric alcohol and water of a stabilizing formulation or with a liquid enzymatic composition.
- the formulation is not required to be a clear solution.
- the formulation is an emulsion having an apparent homogeneous texture.
- the amount of polymer present also depends on the molecular weight of the particular polymer used. The higher the molecular weight of the polymer used, the lower the amount of polymer generally required to stabilize an enzyme.
- the polymer may preferably be used in amounts up to about 50% by weight of the stabilizing formulation. More preferably, the polymer is present from 0.05 to 30% by weight, and most preferably from 1% to 10% by weight. In a preferred embodiment, the polymer, of course, is present in an amount that gives the desired synergistic stabilization of a liquid enzymatic composition when combined with the polyhydric alcohol in a water-based or aqueous formulation.
- the polymer employed in the present invention is poly(cellulosic)ethers.
- the polymer may be substituted or unsubstituted.
- the polymer may have a slight ionic charge, but is preferably non-ionic in nature.
- the polymer is preferably selected from poly(carboxymethylcellulose)ether, poly(hydroxypropylmethylcellulose)ether, poly(hydroxyethylmethylcellulose)ether, poly(hydroxybutylmethylcellulose)ether, poly(hydroxypropylcellulose)ether, and poly(ethylhydroxyethylcellulose)ether. More preferably, the polymer is poly(carboxymethylcellulose)ether.
- Certain poly(cellulosic)ethers used in the present invention, such as poly(carboxymethylcellulose)ether, are sold as salts, i.e. sodium salts, and possess a slight anionic charge.
- Preferable poly(cellulosic)ethers are those with molecular weights ranging from 15,000 to 100,000, but more preferred are those with molecular weights ranging from 20,000 to 75,000.
- the stabilizing formulation also contains a C 2 -C 6 polyhydric alcohol as a second component.
- the C 2 -C 6 polyhydric alcohol acts synergistically with the polymer, described above, to stabilize an enzyme in a liquid enzyme composition.
- the C 2 -C 6 polyhydric alcohol is preferably selected from a glycol and a trihydric alcohol. More preferably, the C 2 -C 6 polyhydric alcohol is glycerol, sorbitol, propylene glycol, butylene glycol, hexylene glycol, or ethylene glycol. Most preferably, the C 2 -C 6 polyhydric alcohol is glycerol.
- the stabilizing formulation contains the C 2 -C 6 polyhydric alcohol in an amount sufficient, with the polymer, to stabilize at least one enzyme in a liquid enzymatic composition.
- the C 2 -C 6 polyhydric alcohol present is 0.50 to 60% by weight of the stabilizing formulation, more preferably, 5 to 50% by weight and, even more preferably, between 10 and 30%.
- a stabilizing formulation or enzymatic composition contains the C 2 -C 6 polyhydric alcohol in a combined amount with the polymer to achieve synergistic stabilization.
- the formulations of the invention are water-based or aqueous formulations containing sufficient water to allow the polymer to be miscible with the formulation and not separate out.
- the C 2 -C 6 polyhydric alcohol is soluble in water, but sufficient water should be present to allow the formulation to form a single phase.
- the formulation is not required to be a clear solution and preferably is an emulsion having an apparent homogeneous texture.
- Water-based formulations may contain additional solvents other than water.
- the stabilizing formulations of the invention can be prepared by mixing the components in any order, the formulations are preferably prepared by adding the desired amount of polymer to a C 2 -C 6 polyhydric alcohol/water mixture.
- the C 2 -C 6 polyhydric alcohol/water mixture can be prepared by means known in the art.
- the mixture can be prepared by simply mixing the desired polyhydric alcohol with an appropriate amount of water, or diluting a previously prepared mixture.
- the preferred mixture of the C 2 -C 6 polyhydric alcohol and water may contain any percentage of C 2 -C 6 alcohol sufficient with the polymer discussed above to stabilize, preferably synergistically, at least one enzyme in a liquid enzymatic composition.
- the mixture is 1-95% by weight of the polyhydric alcohol, or water-soluble polymer thereof; more preferably 10-50% by weight; and most preferably, 30-50% by weight.
- the polyhydric alcohol is glycerol
- the mixture is preferably a 50% by weight glycerol/ water mixture.
- applicant believes that the mixture acts to wet the polymer used in the present invention and the C 2 -C 6 polyhydric alcohol in the mixture, to synergistically stabilize an enzyme.
- the enzyme should possess at least 90% activity after 30 days at 25°C.
- the examples below demonstrate the preferred synergistic stabilization of various enzymes at 50°C after 30 days.
- the stabilizing formulation described here can be employed with a wide variety of enzymes and industrial processes or commercial products.
- the enzymes, industrial processes and commercial products with which this stabilizing formulation can be used include, but are not limited to, those previously discussed.
- the invention also relates to a stabilized liquid enzymatic composition
- a stabilized liquid enzymatic composition comprising at least one poly(cellulosic)ether; a C 2 -C 6 polyhydric alcohol; water; and at least one enzyme.
- the polymer and C 2 -C 6 polyhydric alcohol are present in a combined amount effective to stabilize, preferably to synergistically stabilize, at least one enzyme contained in the liquid enzymatic composition.
- Preferred compositions according to the invention are capable of developing greater viscosities than quantitatively proportional aqueous mixtures with the same polymers.
- the liquid enzymatic composition of this invention can be practiced with a wide variety of enzymes.
- enzymes include, but are not limited to, the enzyme classes and specific enzymes heretofore discussed.
- Enzymes that may be used are derived from animal, plant, fungal, bacterial, and synthetic sources.
- Preferable water dispersible enzymes for this system are proteases, including acid, alkaline, and neutral proteases, which are widely used in the laundry detergent and cheese making industries; amylases, including acid, alkaline, and neutral amylases, used, for example, in the corn syrup industry; lipases, used in developing flavors in cheese, and in the pulp and paper and leather making industries; cellulases, and xylases.
- enzymes are often packaged and sold in concentrated liquid enzymatic compositions to be diluted prior to use. Enzymes can also be supplied in powdered or desiccated form. The amount of enzyme present after dilution of the concentrated enzyme depends on the form in which the enzyme is supplied. In general, the amount of enzyme preferably may range from 0.05 to 40% by weight of a concentrated liquid enzymatic composition, more preferably 0.5 to 25%, and most preferably 10 to 20%.
- the stabilizing formulation of this invention is specifically contemplated for use in concentrated liquid enzymatic compositions as well as with compositions already diluted for use.
- the amount of stabilizing formulation needed to stabilize, or to synergistically stabilize, a concentrated solution can, and most likely will, differ from that for a diluted composition. Determining the appropriate quantity of stabilizing formulation or its components can be readily ascertained by one of ordinary skill in the art using the method set out in the examples below. As known in the art, the amount of enzyme present, however, is dependent upon the activity of the particular enzyme and the desired end use.
- the pH of the final stabilized liquid ⁇ enzymatic composition is preferably from 5.0 to 10.0, but more preferably around 7.0. Most preferably, the system should be allowed to seek its own pH, generally around neutral. But, as understood in the art, adjustment of pH may be necessary with a small amount of acidic or alkaline material.
- the stabilized liquid enzymatic composition may be water-based or aqueous and contain other solvents or additives directed toward the use of the composition in a particular industrial process.
- the stabilized liquid enzymatic composition can contain additives such as surfactants, defoamers, and the like, as are known in the art.
- additives such as surfactants, defoamers, and the like, as are known in the art.
- synergistic stabilization such additives may be added in amounts not interfering with the synergistic stabilization of the liquid enzymatic composition.
- the stabilizing formulation may also act as a dispersant aid for the enzyme in industrial process waters.
- the invention also relates to a method for the preparation of a stabilized liquid enzymatic composition comprising the step of combining at least one enzyme with the inventive stabilizing formulation.
- the invention further relates to a method of using the stabilizing formulation to stabilize a liquid enzymatic composition comprising the step of combining a liquid enzymatic composition with the stabilizing formulation.
- Illustrative and preferred components, as well as the amounts of the components used in the method, are the same as discussed above.
- An alternative method for the preparation of a stabilized liquid enzymatic composition comprises the steps of:
- the polymer added in step (b) may be added alone, as an aqueous dispersion, or as a solution where the polymer is dissolved in water or a suitable organic solvent.
- additives may be added at any time, but preferably prior to step (c), or in a separate step after the enzyme is added.
- Synergism was demonstrated by testing glycerol, designated as Compound A, and poly(carboxymethylcellulose)ether, (CMC), having a 250,000 molecular weight, designated as Compound B.
- CMC poly(carboxymethylcellulose)ether
- Tables 1 and 2 experiments were set up by varying ratios of Compound A to Compound B over a range of concentrations and assaying various types of enzymes for enhanced stabilization of enzymatic activity at 50°C for 30 days. The concentration of each compound required for an assay of 90% of the original enzymatic activity was taken as an end point. The concentrations are expressed as percent by weight of the compound in the final composition including the added enzyme with the balance being water. Water was added to compound A, the glycerol to form a glycerol-water mixture. End points for the compositions containing Compound A and Compound B were then compared with the end points for Compound A alone and Compound B alone.
- Synergism was determined by the method described by Kull, F.C., Eisman, P.C., Sylwestrowicz, H.D., and Mayer, R.L., Applied Microbiology 9: 538-541 (1961) employing the ratio determined by QA Qa + QB Qb where
- Stabilizing formulations of the invention as in Example 1 were tested with another enzyme, Diazyme L-200, a glucoamylase sold by Solvay Enzymes, Inc.
- Diazyme L-200 a glucoamylase sold by Solvay Enzymes, Inc.
- the results, set forth in Tables 3 and 4 also demonstrate enhanced stabilization with this enzyme.
- the sums of QA/Qa + QB/Qb for all compositions containing glycerol (Compound A) and CMC (Compound B) were calculated. Sample calculations are shown for some end points where synergism was evident in this example. As set forth in Table 2 and the sample calculations, these end point values were 0.59, 0.67, 0.67, and 0.84, respectively, indicating the existence of synergism.
- Enzymes with esterase activity were tested with stabilizing formulations according to the invention as in Example 1.
- the results obtained with the enzyme, Lipolase, a lipase sold by Novo Nordisk Bioindustries, Inc., are set forth in Table 3 and indicate the enhanced stabilization of this enzyme.
- the sums of QA/Qa + QB/Qb for all compositions containing aqueous glycerol (Compound A) and CMC (Compound B) were calculated. Sample calculations are shown for some end points where synergism was evident in this example. As set forth in Table 3 and the sample calculations, these end point values were 0.43, 0.37, 0.57, and 0.77, respectively, indicating the existence of synergism.
- the hemicellulase, Pulpzyme HB, a xylanase sold by Novo Nordisk Bioindustrials, Inc. was selected for enhanced stability formulation testing as in Example 1.
- the following results obtained for this example are set forth in Table 4.
- the sums of QA/Qa + QB/Qb for all compositions containing glycerol (Compound A) and CMC (Compound B) were calculated. Sample calculations are shown for those end points where synergism was evident in this example. As set forth in Table 7 and the sample calculations, these end point values were 0.43, 0.53, 0.57, and 0.77, respectively, indicating the existence of synergism.
Abstract
Description
- Qa =
- Percentage (by weight) of aqueous mixture of Compound A, acting alone, which produced an end point,
- Qb =
- Percentage (by weight) of aqueous mixture of Compound B, acting alone, which produced an end point,
- QA =
- Percentage (by weight) of aqueous mixture of Compound A to Compound B, which produced an end point, and
- QB =
- Percentage (by weight) of aqueous mixture of Compound B to Compound A, which produced an end point.
Compound A (% by weight) | ||||||
60 | 30 | 20 | 10 | 5 | 0 | |
Compound B (% by weight) | ||||||
6 | + | + | + | + | + | +* |
3 | + | + | + | + * | +* | - |
2 | + | + | +* | - | - | - |
1 | + | +* | - | - | - | - |
0 | +* | - | - | - | - | - |
(1)(*) = End point of ≥ 90% enzymatic activity after 30 days at 50°C | ||||||
(2)(+) = ≥ 90% enzymatic activity after 30 days at 50° C | ||||||
(3)(-) = < 90% enzymatic activity remaining after 30 days at 50°C | ||||||
(4) Compound A = Glycerol | ||||||
(5) Compound B = CMC |
Calculations: | ||||
Qa | Qb | QA | QB | QA/Qa + QB/Qb |
(%) 60 | 6 | 5 | 3 | 5/60 + 3/6 = 0.58 |
10 | 3 | 10/60 + 3/6 = 0.67 | ||
20 | 2 | 20/60 + 2/6 = 0.67 | ||
30 | 1 | 30/60 + 1/6 = 0.67 |
Compound A (% by weight) | ||||||
60 | 30 | 20 | 10 | 5 | 0 | |
Compound B (% by weight) | ||||||
6 | + | + | + | + | + | +* |
3 | + | + | + | +* | +* | - |
2 | + | +* | +* | - | - | - |
1 | + | - | - | - | - | - |
0 | +* | - | - | - | - | - |
(1)(*) = End point of ≥ 90% enzymatic activity after 30 days at 50°C | ||||||
(2)(+) = ≥ 90% enzymatic activity after 30 days at 50°C | ||||||
(3)(-) = < 90% enzymatic activity remaining after 30 days at 50°C | ||||||
(4) Compound A = Glycerol | ||||||
(5) Compound B = CMC |
Calculations: | ||||
Qa | Qb | QA | QB | QA/Qa + QB/Qb |
(%) 60 | 6 | 5 | 3 | 5/60 + 3/6 = 0.59 |
10 | 3 | 10/60 + 3/6 = 0.67 | ||
20 | 2 | 20/60 + 2/6 = 0.67 | ||
30 | 2 | 30/60 + 2/6 = 0.84 |
Compound A (% by weight) | ||||||
50 | 30 | 20 | 10 | 5 | 0 | |
Compound B (% by weight) | ||||||
6 | + | + | + | + | + | +* |
3 | + | + | + | + | + | - |
2 | + | + | + | + | +* | - |
1 | + | +* | +* | +* | - | - |
0 | +* | - | - | - | - | - |
(1)(*) = End point of ≥ 90% enzymatic activity after 30 days at 50°C | ||||||
(2)(+) = ≥ 90% enzymatic activity after 30 days at 50°C | ||||||
(3)(-) = < 90% enzymatic activity remaining after 30 days at 50°C | ||||||
(4) Compound A = Glycerol | ||||||
(5) Compound B = CMC |
Calculations: | ||||
Qa | Qb | QA | QB | QA/Qa + QB/Qb |
(%) 50 | 6 | 5 | 2 | 5/50 + 2/6 = 0.43 |
10 | 1 | 10/50 + 1/6 = 0.37 | ||
20 | 1 | 20/50 + 1/6 = 0.56 | ||
30 | 1 | 30/50 + 1/6 = 0.76 |
Compound A (% by weight) | ||||||
50 | 30 | 20 | 10 | 5 | 0 | |
Compound B (% by weight) | ||||||
6 | + | + | + | + | + | +* |
3 | + | + | + | + | + | - |
2 | + | + | + | +* | +* | - |
1 | + | +* | +* | - | - | - |
0 | +* | - | - | - | - | - |
(1)(*) = End point of ≥ 90% enzymatic activity after 30 days at 50°C | ||||||
(2)(+) = ≥ 90% enzymatic activity after 30 days at 50°C | ||||||
(3)(-) = < 90% enzymatic activity remaining after 30 days at 50°C | ||||||
(4) Compound A = Glycerol | ||||||
(5) Compound B = CMC |
Calculations: | ||||
Qa | Qb | QA | QB | QA/Qa + QB/Qb |
(%) 50 | 6 | 5 | 2 | 5/50 + 2/6 = 0.43 |
10 | 2 | 10/50 + 2/6 = 0.53 | ||
20 | 1 | 20/50 + 1/6 = 0.57 | ||
30 | 1 | 30/50 + 1/6 = 0.77 |
Claims (12)
- A formulation for stabilizing a liquid enzymatic composition comprising:(a) at least one poly(cellulosic)ether,(b) a C2-C6 polyhydric alcohol, and(c) water,
- The formulation of claim 1 wherein said poly(cellulosic)ether is selected from poly(carboxymethylcellulose)ether, poly(hydroxypropylmethylcellulose)ether, poly(hydroxyethylmethylcellulose)ether, poly(hydroxybutylmethylcellulose)ether, poly(hydroxypropylcellulose)ether, and poly(ethylhydroxyethylcellulose)ether.
- The formulation of claim 1 wherein said C2-C6 polyhydric alcohol is glycerol, sorbitol, propylene glycol, butylene glycol, hexylene glycol, or ethylene glycol and said components (b) and (c) are contained in a mixture of 1-95% by weight of said C2-C6 polyhydric alcohol and the remainder water.
- The formulation of any one of claims 1 to 3 wherein components (a) and (b) are present in a combined amount synergistically effective to stabilize at least one enzyme contained in a liquid enzymatic composition.
- A stabilized liquid enzymatic composition comprising a formulation according to any one of claims 1 to 4 and at least one enzyme.
- The composition of claim 5 wherein said composition is an emulsion.
- A stabilized liquid enzymatic composition comprising a formulation as claimed in any one of claims 1 to 4 and at least one enzyme.
- A method for preparing a liquid stabilized enzymatic composition comprising the step of combining at least one enzyme and a formulation as claimed in any one of claims 1 to 4.
- The method of claim 8 further comprising, before said combining step, the steps of mixing said C2-C6 polyhydric alcohol and said water, and
adding said poly(cellulosic)ether to said C2-C6 polyhydric alcohol and water mixture. - The method of claim 8 or 9 wherein said C2-C6 polyhydric alcohol is glycerol, sorbitol, propylene glycol, butylene glycol, hexylene glycol, or ethylene glycol; said mixture is 1-95% by weight of said C2-C6 polyhydric alcohol and the remainder water; and said at least one enzyme is selected from a protease, amylase, lipase, cellulase, mannase, and xylase.
- Use of a formulation according to any one of claims 1 to 4, to stabilize a liquid enzymatic composition comprising the step of combining a liquid enzymatic composition containing at least one enzyme with said formulation.
- Use according to claim 13 wherein said poly(cellulosic)ether is selected from poly(carboxymethylcellulose)ether and said C2-C6 polyhydric alcohol is glycerol and said at least one enzyme is selected from a protease, amylase, lipase, cellulase, mannase, and xylase.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7256093A | 1993-06-07 | 1993-06-07 | |
PCT/US1994/006522 WO1994029424A1 (en) | 1993-06-07 | 1994-06-06 | Synergistically stabilized liquid enzymatic compositions |
US72560 | 2002-02-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0702712A1 EP0702712A1 (en) | 1996-03-27 |
EP0702712B1 true EP0702712B1 (en) | 1998-12-23 |
Family
ID=22108388
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP94919433A Revoked EP0702712B1 (en) | 1993-06-07 | 1994-06-06 | Synergistically stabilized liquid enzymatic compositions |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0702712B1 (en) |
JP (1) | JPH08510786A (en) |
CN (1) | CN1128543A (en) |
AT (1) | ATE174956T1 (en) |
AU (1) | AU7058694A (en) |
BR (1) | BR9407029A (en) |
CA (1) | CA2164615A1 (en) |
CZ (1) | CZ323095A3 (en) |
DE (1) | DE69415524T2 (en) |
DK (1) | DK0702712T3 (en) |
ES (1) | ES2126764T3 (en) |
FI (1) | FI955851A (en) |
NO (1) | NO954957L (en) |
NZ (1) | NZ267909A (en) |
SG (1) | SG104908A1 (en) |
SK (1) | SK153695A3 (en) |
WO (1) | WO1994029424A1 (en) |
ZA (1) | ZA943640B (en) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7569226B2 (en) | 2001-12-22 | 2009-08-04 | Henkel Kommanditgesellschaft Auf Aktien (Henkel Kgaa) | Alkaline protease from Bacillus sp. (DSM 14392) and washing and cleaning products comprising said alkaline protease |
US7666618B2 (en) | 2004-07-16 | 2010-02-23 | Danisco A/S | Lipolytic enzyme: uses thereof in the food industry |
US7718408B2 (en) | 2003-12-24 | 2010-05-18 | Danisco A/S | Method |
US7718204B2 (en) | 1998-07-21 | 2010-05-18 | Danisco A/S | Foodstuff |
US7803604B2 (en) | 2000-07-28 | 2010-09-28 | Henkel Ag & Co. Kgaa | Amylolytic enzyme extracted from Bacillus sp. A 7-7 (DSM 12368) and washing and cleaning agents containing this novel amylolytic enzyme |
US7807398B2 (en) | 2003-01-17 | 2010-10-05 | Danisco A/S | Method of using lipid acyltransferase |
US7888104B2 (en) | 2000-11-28 | 2011-02-15 | Henkel Ag & Co. Kgaa | Cyclodextrin glucanotransferase (CGTase), obtained from<I>Bacillus agaradherens<λ>(DSM 9948) and detergents and cleaning agents containing said novel cyclodextrin glucanotransferase |
US7906307B2 (en) | 2003-12-24 | 2011-03-15 | Danisco A/S | Variant lipid acyltransferases and methods of making |
US7955814B2 (en) | 2003-01-17 | 2011-06-07 | Danisco A/S | Method |
US7960150B2 (en) | 2007-01-25 | 2011-06-14 | Danisco A/S | Production of a lipid acyltransferase from transformed Bacillus licheniformis cells |
US8012732B2 (en) | 2004-03-12 | 2011-09-06 | Danisco A/S | Fungal lypolytic and amylase enzyme composition and methods using the same |
US8030044B2 (en) | 2003-12-24 | 2011-10-04 | Danisco A/S | Lipid acyltransferases |
USRE43135E1 (en) | 2001-05-18 | 2012-01-24 | Danisco A/S | Method of improving dough and bread quality |
USRE43341E1 (en) | 1995-06-07 | 2012-05-01 | Danisco A/S | Method of improving the properties of a flour dough, a flour dough improving composition and improved food products |
US8652809B2 (en) | 2007-08-17 | 2014-02-18 | Dupont Nutrition Biosciences Aps | Method for producing ultra-heat treatment milk |
US8753858B2 (en) | 2009-12-31 | 2014-06-17 | Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | Reagents and processes for stabilizing alkaline phosphatase or conjugates thereof |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6342381B1 (en) * | 1998-02-27 | 2002-01-29 | Buckman Laboratories Internationals, Inc. | Enzyme stabilization with pre-superpolyamide or pre-fiber-forming polyamide oligomers |
DE69939059D1 (en) * | 1998-05-13 | 2008-08-21 | Novozymes Inc | PROCESS FOR USE OF CELLOBIOSEDEHYDROGENASE IN BAKING |
ES2375492T3 (en) | 2003-01-17 | 2012-03-01 | Danisco A/S | PROCEDURE FOR THE IN-SITU PRODUCTION OF AN EMULSIONANT IN A FOOD. |
DK2505642T3 (en) * | 2009-11-24 | 2017-01-02 | Yfy Biopulp Tech Ltd | Xylanase Composition and Process for Preparation thereof |
CN102269761A (en) | 2010-06-04 | 2011-12-07 | 深圳迈瑞生物医疗电子股份有限公司 | Synthesis process for alkaline phosphatase conjugate |
CN102269762B (en) | 2010-06-04 | 2014-12-10 | 深圳迈瑞生物医疗电子股份有限公司 | Preparation method of conjugate and relative kit |
EP3068861B1 (en) | 2013-11-11 | 2020-03-18 | Ecolab USA Inc. | Multiuse, enzymatic detergent and methods of stabilizing a use solution |
AU2014346509B2 (en) | 2013-11-11 | 2017-02-02 | Ecolab Usa Inc. | High alkaline warewash detergent with enhanced scale control and soil dispersion |
EA036683B1 (en) | 2015-04-10 | 2020-12-08 | Комет Биорефайнинг Инк. | Methods and compositions for the treatment of cellulosic biomass and products produced thereby |
JP7351856B2 (en) | 2018-05-10 | 2023-09-27 | コメット バイオリファイニング インコーポレイテッド | Compositions containing glucose and hemicellulose and uses thereof |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB758049A (en) * | 1953-04-06 | 1956-09-26 | Armour & Co | Improvements in or relating to prolonged-action local anaesthetics |
GB942305A (en) * | 1958-12-23 | 1963-11-20 | Parachem Corp | Improvements in or relating to antiseptic film and method and apparatus for producing the same |
DE2038103A1 (en) * | 1970-07-31 | 1972-02-10 | Henkel & Cie Gmbh | Dish-washing concentrates - contg enzymes, stabilised with sugar alcohols, monosaccharides or disaccharides |
JPS5536317B2 (en) * | 1972-04-22 | 1980-09-19 | ||
SU889689A1 (en) * | 1979-09-05 | 1981-12-15 | Всесоюзный научно-исследовательский и проектный институт химической промышленности | Detergent for laundering |
IT1129814B (en) * | 1980-07-02 | 1986-06-11 | Unilever Nv | LIQUID ENZYMATIC DETERGENT COMPOSITION |
FR2488797A1 (en) * | 1980-08-19 | 1982-02-26 | Lhd Lab Hygiene Dietetique | DERMATOLOGICAL COMPOSITION, PROCESS FOR PREPARATION AND APPLICATION IN THE FIELD OF DRESSINGS |
FR2519552B1 (en) * | 1982-01-12 | 1987-02-27 | Mechin Jean Claude | PROCESS FOR STABILIZING LYSOZYME IN A LIQUID OR SEMI-LIQUID COMPOSITION, AND STABILIZED COMPOSITION BASED ON LYSOZYME |
FR2531337A1 (en) * | 1982-08-04 | 1984-02-10 | Hoechst Lab | NEW ORALLY ADMINISTRATIVE GALENIC FORMS, SOLUBLE DIMETHYLXANTHINE DERIVATIVES |
NZ216792A (en) * | 1985-07-26 | 1989-04-26 | Colgate Palmolive Co | Stabilised,fabric-softening built detergent compositions containing enzymes and swelling bentonite clay |
JPH03127988A (en) * | 1989-10-13 | 1991-05-31 | Central Glass Co Ltd | Stabilization of enzyme |
DE4211883C1 (en) * | 1992-04-09 | 1993-03-04 | Desitin Arzneimittel Gmbh, 2000 Hamburg, De | Stable, heat-sterilisable carbamazepine soln. for parenteral admin. - comprises carbamazepine dissolved in tetra:hydro:furfuryl alcohol, polyethylene glycol ether, water and polyvinyl pyrrolidone |
-
1994
- 1994-05-25 ZA ZA943640A patent/ZA943640B/en unknown
- 1994-06-06 CZ CZ953230A patent/CZ323095A3/en unknown
- 1994-06-06 EP EP94919433A patent/EP0702712B1/en not_active Revoked
- 1994-06-06 CN CN94193012A patent/CN1128543A/en active Pending
- 1994-06-06 WO PCT/US1994/006522 patent/WO1994029424A1/en not_active Application Discontinuation
- 1994-06-06 AU AU70586/94A patent/AU7058694A/en not_active Abandoned
- 1994-06-06 NZ NZ267909A patent/NZ267909A/en unknown
- 1994-06-06 CA CA002164615A patent/CA2164615A1/en not_active Abandoned
- 1994-06-06 SK SK1536-95A patent/SK153695A3/en unknown
- 1994-06-06 DK DK94919433T patent/DK0702712T3/en active
- 1994-06-06 BR BR9407029A patent/BR9407029A/en not_active Application Discontinuation
- 1994-06-06 ES ES94919433T patent/ES2126764T3/en not_active Expired - Lifetime
- 1994-06-06 DE DE69415524T patent/DE69415524T2/en not_active Revoked
- 1994-06-06 AT AT94919433T patent/ATE174956T1/en not_active IP Right Cessation
- 1994-06-06 JP JP7502105A patent/JPH08510786A/en not_active Ceased
- 1994-06-06 SG SG9605931A patent/SG104908A1/en unknown
-
1995
- 1995-12-05 FI FI955851A patent/FI955851A/en not_active Application Discontinuation
- 1995-12-06 NO NO954957A patent/NO954957L/en not_active Application Discontinuation
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE43341E1 (en) | 1995-06-07 | 2012-05-01 | Danisco A/S | Method of improving the properties of a flour dough, a flour dough improving composition and improved food products |
US7972638B2 (en) | 1998-07-21 | 2011-07-05 | Danisco A/S | Foodstuff |
US8163315B2 (en) | 1998-07-21 | 2012-04-24 | Danisco A/S | Foodstuff |
US7781001B2 (en) | 1998-07-21 | 2010-08-24 | Danisco A/S | Foodstuff |
US7718204B2 (en) | 1998-07-21 | 2010-05-18 | Danisco A/S | Foodstuff |
US7803604B2 (en) | 2000-07-28 | 2010-09-28 | Henkel Ag & Co. Kgaa | Amylolytic enzyme extracted from Bacillus sp. A 7-7 (DSM 12368) and washing and cleaning agents containing this novel amylolytic enzyme |
US7888104B2 (en) | 2000-11-28 | 2011-02-15 | Henkel Ag & Co. Kgaa | Cyclodextrin glucanotransferase (CGTase), obtained from<I>Bacillus agaradherens<λ>(DSM 9948) and detergents and cleaning agents containing said novel cyclodextrin glucanotransferase |
USRE43135E1 (en) | 2001-05-18 | 2012-01-24 | Danisco A/S | Method of improving dough and bread quality |
US7569226B2 (en) | 2001-12-22 | 2009-08-04 | Henkel Kommanditgesellschaft Auf Aktien (Henkel Kgaa) | Alkaline protease from Bacillus sp. (DSM 14392) and washing and cleaning products comprising said alkaline protease |
US8278062B2 (en) | 2003-01-14 | 2012-10-02 | Dupont Nutrition Biosciences Aps | Method of using lipid acyltransferase |
US7955813B2 (en) | 2003-01-17 | 2011-06-07 | Danisco, A/S | Method of using lipid acyltransferase |
US7807398B2 (en) | 2003-01-17 | 2010-10-05 | Danisco A/S | Method of using lipid acyltransferase |
US8003095B2 (en) | 2003-01-17 | 2011-08-23 | Danisco A/S | Method of using lipid acyltransferase |
US7955814B2 (en) | 2003-01-17 | 2011-06-07 | Danisco A/S | Method |
US7718408B2 (en) | 2003-12-24 | 2010-05-18 | Danisco A/S | Method |
US8440435B2 (en) | 2003-12-24 | 2013-05-14 | Dupont Nutrition Biosciences Aps | Method for reducing 1,2-diglyceride content of an edible oil |
US8030044B2 (en) | 2003-12-24 | 2011-10-04 | Danisco A/S | Lipid acyltransferases |
US7906307B2 (en) | 2003-12-24 | 2011-03-15 | Danisco A/S | Variant lipid acyltransferases and methods of making |
US8012732B2 (en) | 2004-03-12 | 2011-09-06 | Danisco A/S | Fungal lypolytic and amylase enzyme composition and methods using the same |
US7666618B2 (en) | 2004-07-16 | 2010-02-23 | Danisco A/S | Lipolytic enzyme: uses thereof in the food industry |
US8192782B2 (en) | 2004-07-16 | 2012-06-05 | Danisco A/S | Enzymatic oil-degumming method |
US8535900B2 (en) | 2004-07-16 | 2013-09-17 | Dupont Nutrition Biosciences Aps | Lipolytic enzyme uses thereof in the food industry |
US8889371B2 (en) | 2004-07-16 | 2014-11-18 | Dupont Nutrition Biosciences Aps | Lipolytic enzyme: uses thereof in the food industry |
US7960150B2 (en) | 2007-01-25 | 2011-06-14 | Danisco A/S | Production of a lipid acyltransferase from transformed Bacillus licheniformis cells |
US8652809B2 (en) | 2007-08-17 | 2014-02-18 | Dupont Nutrition Biosciences Aps | Method for producing ultra-heat treatment milk |
US8753858B2 (en) | 2009-12-31 | 2014-06-17 | Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | Reagents and processes for stabilizing alkaline phosphatase or conjugates thereof |
Also Published As
Publication number | Publication date |
---|---|
DE69415524T2 (en) | 1999-05-20 |
ES2126764T3 (en) | 1999-04-01 |
NO954957L (en) | 1995-12-07 |
BR9407029A (en) | 1996-03-19 |
NZ267909A (en) | 1996-09-25 |
ZA943640B (en) | 1995-01-26 |
JPH08510786A (en) | 1996-11-12 |
CZ323095A3 (en) | 1996-05-15 |
NO954957D0 (en) | 1995-12-06 |
EP0702712A1 (en) | 1996-03-27 |
CA2164615A1 (en) | 1994-12-22 |
CN1128543A (en) | 1996-08-07 |
FI955851A0 (en) | 1995-12-05 |
SG104908A1 (en) | 2004-07-30 |
DE69415524D1 (en) | 1999-02-04 |
DK0702712T3 (en) | 1999-08-23 |
AU7058694A (en) | 1995-01-03 |
FI955851A (en) | 1995-12-05 |
WO1994029424A1 (en) | 1994-12-22 |
ATE174956T1 (en) | 1999-01-15 |
SK153695A3 (en) | 1996-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0702712B1 (en) | Synergistically stabilized liquid enzymatic compositions | |
EP0670894B1 (en) | Stabilized liquid enzymatic compositions | |
US5780283A (en) | Enzyme stabilization by oxygen-containing block copolymers | |
CA2180366C (en) | Enzymes for recreational water | |
US6342381B1 (en) | Enzyme stabilization with pre-superpolyamide or pre-fiber-forming polyamide oligomers | |
EP0399681B1 (en) | Method of laundering fabrics | |
NZ314287A (en) | Stabilized liquid enzyme compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19960105 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
RAX | Requested extension states of the european patent have changed |
Free format text: SI PAYMENT 960105 |
|
17Q | First examination report despatched |
Effective date: 19960610 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: SI PAYMENT 960105 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981223 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981223 |
|
REF | Corresponds to: |
Ref document number: 174956 Country of ref document: AT Date of ref document: 19990115 Kind code of ref document: T |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: A. BRAUN, BRAUN, HERITIER, ESCHMANN AG PATENTANWAE Ref country code: CH Ref legal event code: EP |
|
REF | Corresponds to: |
Ref document number: 69415524 Country of ref document: DE Date of ref document: 19990204 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
ITF | It: translation for a ep patent filed |
Owner name: STUDIO FERRARIO |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2126764 Country of ref document: ES Kind code of ref document: T3 |
|
ET | Fr: translation filed | ||
REG | Reference to a national code |
Ref country code: PT Ref legal event code: SC4A Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 19981231 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 19990630 Year of fee payment: 6 Ref country code: DK Payment date: 19990630 Year of fee payment: 6 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PT Payment date: 19990702 Year of fee payment: 6 Ref country code: IE Payment date: 19990702 Year of fee payment: 6 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GR Payment date: 19990705 Year of fee payment: 6 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 19990706 Year of fee payment: 6 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: MC Payment date: 19990707 Year of fee payment: 6 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 19990709 Year of fee payment: 6 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
PLBQ | Unpublished change to opponent data |
Free format text: ORIGINAL CODE: EPIDOS OPPO |
|
PLBI | Opposition filed |
Free format text: ORIGINAL CODE: 0009260 |
|
PLBQ | Unpublished change to opponent data |
Free format text: ORIGINAL CODE: EPIDOS OPPO |
|
PLBI | Opposition filed |
Free format text: ORIGINAL CODE: 0009260 |
|
PLBF | Reply of patent proprietor to notice(s) of opposition |
Free format text: ORIGINAL CODE: EPIDOS OBSO |
|
26 | Opposition filed |
Opponent name: HENKEL KGAA Effective date: 19990923 |
|
26 | Opposition filed |
Opponent name: UNILEVER N.V. Effective date: 19990922 Opponent name: HENKEL KGAA Effective date: 19990923 |
|
NLR1 | Nl: opposition has been filed with the epo |
Opponent name: HENKEL KGAA |
|
NLR1 | Nl: opposition has been filed with the epo |
Opponent name: UNILEVER N.V. Opponent name: HENKEL KGAA |
|
PLBF | Reply of patent proprietor to notice(s) of opposition |
Free format text: ORIGINAL CODE: EPIDOS OBSO |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20000606 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20000606 Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20000606 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20000629 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20000630 Year of fee payment: 7 Ref country code: FR Payment date: 20000630 Year of fee payment: 7 Ref country code: AT Payment date: 20000630 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20000705 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20000714 Year of fee payment: 7 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20000727 Year of fee payment: 7 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20001231 Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20001231 Ref country code: GR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20001231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20010101 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee |
Effective date: 20010101 |
|
RDAH | Patent revoked |
Free format text: ORIGINAL CODE: EPIDOS REVO |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: MM4A Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20001231 |
|
RDAG | Patent revoked |
Free format text: ORIGINAL CODE: 0009271 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: PATENT REVOKED |
|
27W | Patent revoked |
Effective date: 20010419 |
|
GBPR | Gb: patent revoked under art. 102 of the ep convention designating the uk as contracting state |
Free format text: 20010419 |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: MF4A Effective date: 20010903 |
|
PLAB | Opposition data, opponent's data or that of the opponent's representative modified |
Free format text: ORIGINAL CODE: 0009299OPPO |